Cadence Pharmaceuticals, Inc. May Buy Incline Therapeutics for up to $285 Million

Published: Jun 22, 2010

Silicon Valley / San Jose Business Journal -- Cadence Pharmaceuticals Inc. on Monday said it has acquired an option to buy Incline Therapeutics Inc.for up to $285 million.

Back to news